世界の肝がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Liver Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4434 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、肝がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肝がん分子診断の市場動向 ・企業の競争状況、市場シェア ・肝がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・肝がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・肝がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・肝がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kingmed、Geneis、Unitedgene、Inmedi、ApexHealth、KHB、Tellgen、Sansure、Mole、Premed） ・結論

A molecular approach for diagnosing liver cancer

Market Analysis and Insights: Global Liver Cancer Molecular Diagnostics Market
The global Liver Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Cancer Molecular Diagnostics market.

Global Liver Cancer Molecular Diagnostics Scope and Market Size
Liver Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Kingmed
Geneis
Unitedgene
Inmedi
ApexHealth
KHB
Tellgen
Sansure
Mole
Premed

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Liver Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Liver Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Liver Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Liver Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Liver Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Liver Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Liver Cancer Molecular Diagnostics Market Trends
2.3.2 Liver Cancer Molecular Diagnostics Market Drivers
2.3.3 Liver Cancer Molecular Diagnostics Market Challenges
2.3.4 Liver Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Liver Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Liver Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Liver Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Liver Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Cancer Molecular Diagnostics Revenue
3.4 Global Liver Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Liver Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Molecular Diagnostics Revenue in 2020
3.5 Liver Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Liver Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Liver Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Liver Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Liver Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Liver Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Liver Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Liver Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Liver Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Liver Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Liver Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Liver Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Liver Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Liver Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Liver Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Liver Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Liver Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Liver Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Liver Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Liver Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Liver Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Liver Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Liver Cancer Molecular Diagnostics Introduction
11.1.4 Kingmed Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Kingmed Recent Development
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Liver Cancer Molecular Diagnostics Introduction
11.2.4 Geneis Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Geneis Recent Development
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Liver Cancer Molecular Diagnostics Introduction
11.3.4 Unitedgene Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Unitedgene Recent Development
11.4 Inmedi
11.4.1 Inmedi Company Details
11.4.2 Inmedi Business Overview
11.4.3 Inmedi Liver Cancer Molecular Diagnostics Introduction
11.4.4 Inmedi Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Inmedi Recent Development
11.5 ApexHealth
11.5.1 ApexHealth Company Details
11.5.2 ApexHealth Business Overview
11.5.3 ApexHealth Liver Cancer Molecular Diagnostics Introduction
11.5.4 ApexHealth Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 ApexHealth Recent Development
11.6 KHB
11.6.1 KHB Company Details
11.6.2 KHB Business Overview
11.6.3 KHB Liver Cancer Molecular Diagnostics Introduction
11.6.4 KHB Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 KHB Recent Development
11.7 Tellgen
11.7.1 Tellgen Company Details
11.7.2 Tellgen Business Overview
11.7.3 Tellgen Liver Cancer Molecular Diagnostics Introduction
11.7.4 Tellgen Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Tellgen Recent Development
11.8 Sansure
11.8.1 Sansure Company Details
11.8.2 Sansure Business Overview
11.8.3 Sansure Liver Cancer Molecular Diagnostics Introduction
11.8.4 Sansure Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Sansure Recent Development
11.9 Mole
11.9.1 Mole Company Details
11.9.2 Mole Business Overview
11.9.3 Mole Liver Cancer Molecular Diagnostics Introduction
11.9.4 Mole Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Mole Recent Development
11.10 Premed
11.10.1 Premed Company Details
11.10.2 Premed Business Overview
11.10.3 Premed Liver Cancer Molecular Diagnostics Introduction
11.10.4 Premed Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Premed Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Liver Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Liver Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Liver Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Liver Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Liver Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Liver Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Liver Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Liver Cancer Molecular Diagnostics Market Trends
Table 13. Liver Cancer Molecular Diagnostics Market Drivers
Table 14. Liver Cancer Molecular Diagnostics Market Challenges
Table 15. Liver Cancer Molecular Diagnostics Market Restraints
Table 16. Global Liver Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Liver Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Liver Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Liver Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Liver Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Liver Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Liver Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Liver Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Liver Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Liver Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kingmed Company Details
Table 64. Kingmed Business Overview
Table 65. Kingmed Liver Cancer Molecular Diagnostics Product
Table 66. Kingmed Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Kingmed Recent Development
Table 68. Geneis Company Details
Table 69. Geneis Business Overview
Table 70. Geneis Liver Cancer Molecular Diagnostics Product
Table 71. Geneis Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Geneis Recent Development
Table 73. Unitedgene Company Details
Table 74. Unitedgene Business Overview
Table 75. Unitedgene Liver Cancer Molecular Diagnostics Product
Table 76. Unitedgene Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Unitedgene Recent Development
Table 78. Inmedi Company Details
Table 79. Inmedi Business Overview
Table 80. Inmedi Liver Cancer Molecular Diagnostics Product
Table 81. Inmedi Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Inmedi Recent Development
Table 83. ApexHealth Company Details
Table 84. ApexHealth Business Overview
Table 85. ApexHealth Liver Cancer Molecular Diagnostics Product
Table 86. ApexHealth Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. ApexHealth Recent Development
Table 88. KHB Company Details
Table 89. KHB Business Overview
Table 90. KHB Liver Cancer Molecular Diagnostics Product
Table 91. KHB Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. KHB Recent Development
Table 93. Tellgen Company Details
Table 94. Tellgen Business Overview
Table 95. Tellgen Liver Cancer Molecular Diagnostics Product
Table 96. Tellgen Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Tellgen Recent Development
Table 98. Sansure Company Details
Table 99. Sansure Business Overview
Table 100. Sansure Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Sansure Recent Development
Table 102. Mole Company Details
Table 103. Mole Business Overview
Table 104. Mole Liver Cancer Molecular Diagnostics Product
Table 105. Mole Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Mole Recent Development
Table 107. Premed Company Details
Table 108. Premed Business Overview
Table 109. Premed Liver Cancer Molecular Diagnostics Product
Table 110. Premed Revenue in Liver Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Premed Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Liver Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Liver Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Liver Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Liver Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Liver Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Liver Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Liver Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Liver Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Liver Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Liver Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Liver Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Liver Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Liver Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Liver Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Liver Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Liver Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Liver Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Liver Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Liver Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Liver Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Liver Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Liver Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Liver Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Liver Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Liver Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Liver Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kingmed Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Geneis Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Unitedgene Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Inmedi Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. ApexHealth Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. KHB Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Tellgen Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Sansure Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Mole Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Premed Revenue Growth Rate in Liver Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---